Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Obituary: Gerd Döring.

Quinton PM, Mastella G, Worlitzsch D.

Int J Biochem Cell Biol. 2014 Jul;52:5-6. No abstract available.

PMID:
24987762
2.

SFTA3, a novel protein of the lung: three-dimensional structure, characterisation and immune activation.

Schicht M, Rausch F, Finotto S, Mathews M, Mattil A, Schubert M, Koch B, Traxdorf M, Bohr C, Worlitzsch D, Brandt W, Garreis F, Sel S, Paulsen F, Bräuer L.

Eur Respir J. 2014 Aug;44(2):447-56. doi: 10.1183/09031936.00179813. Epub 2014 Apr 17.

3.

Neutrophil elastase-mediated increase in airway temperature during inflammation.

Schmidt A, Belaaouaj A, Bissinger R, Koller G, Malleret L, D'Orazio C, Facchinelli M, Schulte-Hubbert B, Molinaro A, Holst O, Hammermann J, Schniederjans M, Meyer KC, Damkiaer S, Piacentini G, Assael B, Bruce K, Häußler S, LiPuma JJ, Seelig J, Worlitzsch D, Döring G.

J Cyst Fibros. 2014 Dec;13(6):623-31. doi: 10.1016/j.jcf.2014.03.004. Epub 2014 Apr 6.

4.

Colonization and infection due to multi-resistant bacteria in neonates: a single center analysis.

Haase R, Worlitzsch D, Schmidt F, Kulka R, Kekulé AS, Körholz D.

Klin Padiatr. 2014 Jan;226(1):8-12. doi: 10.1055/s-0033-1354376. Epub 2013 Oct 28.

PMID:
24166089
5.

Lactate levels in airways of patients with cystic fibrosis and idiopathic pulmonary fibrosis.

Worlitzsch D, Meyer KC, Döring G.

Am J Respir Crit Care Med. 2013 Jul 1;188(1):111. doi: 10.1164/rccm.201211-2042LE. No abstract available.

PMID:
23815725
6.

[Immunosuppressive treatment as a risk factor for the occurrence of clostridium difficile infection (CDI)].

Lübbert C, Johann C, Kekulé AS, Worlitzsch D, Weis S, Mössner J, Behl S, Seufferlein T.

Z Gastroenterol. 2013 Nov;51(11):1251-8. doi: 10.1055/s-0033-1335505. Epub 2013 May 21. German.

PMID:
23696115
7.

[Results of surveillance cultures on a neonatal intensive care unit: a retrospective analysis].

Haase R, Voigt P, Kekulé A, Worlitzsch D, Schmidt F, Körholz D.

Z Geburtshilfe Neonatol. 2013 Apr;217(2):56-60. doi: 10.1055/s-0033-1341451. Epub 2013 Apr 26. German.

PMID:
23625766
8.

Staphylococcus aureus and Pseudomonas aeruginosa express and secrete human surfactant proteins.

Bräuer L, Schicht M, Worlitzsch D, Bensel T, Sawers RG, Paulsen F.

PLoS One. 2013;8(1):e53705. doi: 10.1371/journal.pone.0053705. Epub 2013 Jan 22.

9.

Surgical site infections after coronary artery bypass graft surgery: incidence, perioperative hospital stay, readmissions, and revision surgeries.

Cristofolini M, Worlitzsch D, Wienke A, Silber RE, Borneff-Lipp M.

Infection. 2012 Aug;40(4):397-404. doi: 10.1007/s15010-012-0275-0. Epub 2012 Jun 15.

PMID:
22700379
10.

[Antibiotic treatment of enterococcal infections in gastroenterology with daptomycin - first experiences from the EU-CORE registry study (European Cubicin® Outcomes Registry and Experience)].

Lübbert C, Wilhelms D, Worlitzsch D, Ettrich TJ, Behl S, Seufferlein T.

Z Gastroenterol. 2012 Apr;50(4):373-81. doi: 10.1055/s-0031-1282031. Epub 2012 Mar 19. German.

PMID:
22430297
11.

Expression and regulation of antimicrobial peptide psoriasin (S100A7) at the ocular surface and in the lacrimal apparatus.

Garreis F, Gottschalt M, Schlorf T, Gläser R, Harder J, Worlitzsch D, Paulsen FP.

Invest Ophthalmol Vis Sci. 2011 Jul 1;52(7):4914-22. doi: 10.1167/iovs.10-6598.

PMID:
21551409
12.

Lactate in cystic fibrosis sputum.

Bensel T, Stotz M, Borneff-Lipp M, Wollschläger B, Wienke A, Taccetti G, Campana S, Meyer KC, Jensen PØ, Lechner U, Ulrich M, Döring G, Worlitzsch D.

J Cyst Fibros. 2011 Jan;10(1):37-44. doi: 10.1016/j.jcf.2010.09.004. Epub 2010 Oct 13.

13.

Roles of human beta-defensins in innate immune defense at the ocular surface: arming and alarming corneal and conjunctival epithelial cells.

Garreis F, Schlorf T, Worlitzsch D, Steven P, Bräuer L, Jäger K, Paulsen FP.

Histochem Cell Biol. 2010 Jul;134(1):59-73. doi: 10.1007/s00418-010-0713-y. Epub 2010 Jun 5.

PMID:
20526610
14.

Alveolar inflammation in cystic fibrosis.

Ulrich M, Worlitzsch D, Viglio S, Siegmann N, Iadarola P, Shute JK, Geiser M, Pier GB, Friedel G, Barr ML, Schuster A, Meyer KC, Ratjen F, Bjarnsholt T, Gulbins E, Döring G.

J Cyst Fibros. 2010 May;9(3):217-27. doi: 10.1016/j.jcf.2010.03.001. Epub 2010 Mar 29.

15.

Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.

Worlitzsch D, Rintelen C, Böhm K, Wollschläger B, Merkel N, Borneff-Lipp M, Döring G.

Clin Microbiol Infect. 2009 May;15(5):454-60. doi: 10.1111/j.1469-0691.2008.02659.x. Epub 2009 Jan 22.

16.

Detection and regulation of cationic amino acid transporters in healthy and diseased ocular surface.

Jäger K, Bönisch U, Risch M, Worlitzsch D, Paulsen F.

Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1112-21. doi: 10.1167/iovs.08-2368. Epub 2008 Nov 7.

PMID:
18997084
17.

Regulation of MUC16 by inflammatory mediators in ocular surface epithelial cell lines.

Paulsen F, Jäger K, Worlitzsch D, Bräuer L, Schulze U, Schäfer G, Sel S.

Ann Anat. 2008;190(1):59-70. doi: 10.1016/j.aanat.2007.05.001. Epub 2007 Oct 1.

PMID:
18342144
18.

Virulence of Burkholderia cepacia complex strains in gp91phox-/- mice.

Sousa SA, Ulrich M, Bragonzi A, Burke M, Worlitzsch D, Leitão JH, Meisner C, Eberl L, Sá-Correia I, Döring G.

Cell Microbiol. 2007 Dec;9(12):2817-25. Epub 2007 Jul 11.

PMID:
17627623
19.

Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Bragonzi A, Wiehlmann L, Klockgether J, Cramer N, Worlitzsch D, Döring G, Tümmler B.

Microbiology. 2006 Nov;152(Pt 11):3261-9.

PMID:
17074897
20.

Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model.

Bragonzi A, Worlitzsch D, Pier GB, Timpert P, Ulrich M, Hentzer M, Andersen JB, Givskov M, Conese M, Doring G.

J Infect Dis. 2005 Aug 1;192(3):410-9. Epub 2005 Jun 24.

21.

Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis.

Paul K, Rietschel E, Ballmann M, Griese M, Worlitzsch D, Shute J, Chen C, Schink T, Döring G, van Koningsbruggen S, Wahn U, Ratjen F; Bronchoalveolar Lavage for the Evaluation of Antiinflammatory Treatment Study Group.

Am J Respir Crit Care Med. 2004 Mar 15;169(6):719-25. Epub 2003 Dec 18.

PMID:
14684561
22.

Inflammation in cystic fibrosis and its management.

Döring G, Worlitzsch D.

Paediatr Respir Rev. 2000 Jun;1(2):101-6. Review.

PMID:
12531101
23.

Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients.

Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC, Döring G.

J Clin Invest. 2002 Feb;109(3):317-25.

24.

Pseudomonas aeruginosa mutations in lasI and rhlI quorum sensing systems result in milder chronic lung infection.

Wu H, Song Z, Givskov M, Doring G, Worlitzsch D, Mathee K, Rygaard J, Høiby N.

Microbiology. 2001 May;147(Pt 5):1105-13.

PMID:
11320114
25.

Effects of amoxicillin, gentamicin, and moxifloxacin on the hemolytic activity of Staphylococcus aureus in vitro and in vivo.

Worlitzsch D, Kaygin H, Steinhuber A, Dalhoff A, Botzenhart K, Döring G.

Antimicrob Agents Chemother. 2001 Jan;45(1):196-202.

26.

MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients.

Viglio S, Iadarola P, Lupi A, Trisolini R, Tinelli C, Balbi B, Grassi V, Worlitzsch D, Döring G, Meloni F, Meyer KC, Dowson L, Hill SL, Stockley RA, Luisetti M.

Eur Respir J. 2000 Jun;15(6):1039-45.

27.

Simultaneous determination of Pseudomonas aeruginosa elastase, human leukocyte elastase and cathepsin G activities by micellar electrokinetic chromatography.

Viglio S, Luisetti M, Zanaboni G, Döring G, Worlitzsch D, Cetta G, Iadarola P.

J Chromatogr A. 1999 Jun 18;846(1-2):125-34.

PMID:
10420604
28.

Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis.

Worlitzsch D, Herberth G, Ulrich M, Döring G.

Eur Respir J. 1998 Feb;11(2):377-83.

29.

[Regulation of Staphylococcus aureus capsular polysaccharide type 5: in vitro and in vivo inhibition by CO2].

Herbert S, Worlitzsch D, Dassy B, Boutonnier A, Fournier JM, Bellon G, Dalhoff A, Döring G.

Pneumologie. 1997 Nov;51(11):1043-50. Review. German.

PMID:
9471626
30.

Regulation of Staphylococcus aureus capsular polysaccharide type 5: CO2 inhibition in vitro and in vivo.

Herbert S, Worlitzsch D, Dassy B, Boutonnier A, Fournier JM, Bellon G, Dalhoff A, Döring G.

J Infect Dis. 1997 Aug;176(2):431-8.

PMID:
9237709
31.

[Reactive oxygen species and arachidonic acid metabolites of polymorphonuclear leukocytes].

Döring G, Worlitzsch D.

Immun Infekt. 1995 Oct;23(5):148-57. Review. German.

PMID:
8530125
32.

Molecular epidemiology of Pseudomonas aeruginosa--urinary tract infections in paraplegic patients.

Worlitzsch D, Wolz C, Botzenhart K, Hansis M, Burgdörfer H, Ogle JW, Döring G.

Zentralbl Hyg Umweltmed. 1989 Nov;189(2):175-84.

PMID:
2513821

Supplemental Content

Loading ...
Support Center